These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Control of vascular changes by renin-angiotensin-aldosterone system in salt-sensitive hypertension. Zeng ZH; Luo BH; Gao YJ; Su CJ; He CC; Yi JJ; Li N; Lee RM Eur J Pharmacol; 2004 Oct; 503(1-3):129-33. PubMed ID: 15496307 [TBL] [Abstract][Full Text] [Related]
3. Activation of the Renin-Angiotensin system mediates the effects of dietary salt intake on atherogenesis in the apolipoprotein E knockout mouse. Tikellis C; Pickering RJ; Tsorotes D; Huet O; Chin-Dusting J; Cooper ME; Thomas MC Hypertension; 2012 Jul; 60(1):98-105. PubMed ID: 22647892 [TBL] [Abstract][Full Text] [Related]
4. Mineralocorticoid receptor antagonist for renal protection. Ma TK; Szeto CC Ren Fail; 2012; 34(6):810-7. PubMed ID: 22463731 [TBL] [Abstract][Full Text] [Related]
5. Salt, the renin-angiotensin-aldosterone system and resistant hypertension. Shimosawa T Hypertens Res; 2013 Aug; 36(8):657-60. PubMed ID: 23912973 [TBL] [Abstract][Full Text] [Related]
6. Renal tubule angiotensin II type 1 receptor-associated protein promotes natriuresis and inhibits salt-sensitive blood pressure elevation. Wakui H; Uneda K; Tamura K; Ohsawa M; Azushima K; Kobayashi R; Ohki K; Dejima T; Kanaoka T; Tsurumi-Ikeya Y; Matsuda M; Haruhara K; Nishiyama A; Yabana M; Fujikawa T; Yamashita A; Umemura S J Am Heart Assoc; 2015 Mar; 4(3):e001594. PubMed ID: 25792129 [TBL] [Abstract][Full Text] [Related]
7. Long-term regulation of ENaC expression in kidney by angiotensin II. Beutler KT; Masilamani S; Turban S; Nielsen J; Brooks HL; Ageloff S; Fenton RA; Packer RK; Knepper MA Hypertension; 2003 May; 41(5):1143-50. PubMed ID: 12682079 [TBL] [Abstract][Full Text] [Related]
8. Eplerenone-Resistant Salt-Sensitive Hypertension in Nedd4-2 C2 KO Mice. Kino T; Ishigami T; Murata T; Doi H; Nakashima-Sasaki R; Chen L; Sugiyama M; Azushima K; Wakui H; Minegishi S; Tamura K Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28604611 [TBL] [Abstract][Full Text] [Related]
9. Salt-dependent inhibition of epithelial Na+ channel-mediated sodium reabsorption in the aldosterone-sensitive distal nephron by bradykinin. Mamenko M; Zaika O; Doris PA; Pochynyuk O Hypertension; 2012 Nov; 60(5):1234-41. PubMed ID: 23033373 [TBL] [Abstract][Full Text] [Related]
10. Renal arteriolar injury by salt intake contributes to salt memory for the development of hypertension. Oguchi H; Sasamura H; Shinoda K; Morita S; Kono H; Nakagawa K; Ishiguro K; Hayashi K; Nakamura M; Azegami T; Oya M; Itoh H Hypertension; 2014 Oct; 64(4):784-91. PubMed ID: 24980670 [TBL] [Abstract][Full Text] [Related]
11. Sodium transporter abundance profiling in kidney: effect of spironolactone. Nielsen J; Kwon TH; Masilamani S; Beutler K; Hager H; Nielsen S; Knepper MA Am J Physiol Renal Physiol; 2002 Nov; 283(5):F923-33. PubMed ID: 12372767 [TBL] [Abstract][Full Text] [Related]
12. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats. Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697 [TBL] [Abstract][Full Text] [Related]
14. Direct regulation of ENaC by bradykinin in the distal nephron. Implications for renal sodium handling. Mamenko M; Zaika O; Pochynyuk O Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):122-9. PubMed ID: 24378775 [TBL] [Abstract][Full Text] [Related]
15. Dual blockade of aldosterone and angiotensin II additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney. Onozato ML; Tojo A; Kobayashi N; Goto A; Matsuoka H; Fujita T Nephrol Dial Transplant; 2007 May; 22(5):1314-22. PubMed ID: 17324946 [TBL] [Abstract][Full Text] [Related]
16. Compensatory up-regulation of angiotensin II subtype 1 receptors in alpha ENaC knockout heterozygous mice. Wang Q; Hummler E; Maillard M; Nussberger J; Rossier BC; Brunner HR; Burnier M Kidney Int; 2001 Jun; 59(6):2216-21. PubMed ID: 11380824 [TBL] [Abstract][Full Text] [Related]
17. A nonpeptide, piperidine renin inhibitor provides renal and cardiac protection in double-transgenic mice expressing human renin and angiotensinogen genes. Major TC; Olszewski B; Rosebury W; Okerberg C; Carlson T; Ostroski R; Schroeder R; Kowala MC; Leadley R Cardiovasc Drugs Ther; 2008 Dec; 22(6):469-78. PubMed ID: 18679781 [TBL] [Abstract][Full Text] [Related]
18. Dysregulation of angiotensin II synthesis is associated with salt sensitivity in the spontaneous hypertensive rat. Hodge G; Ye VZ; Duggan KA Acta Physiol Scand; 2002 Mar; 174(3):209-15. PubMed ID: 11906319 [TBL] [Abstract][Full Text] [Related]
19. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial. Matthesen SK; Larsen T; Vase H; Lauridsen TG; Jensen JM; Pedersen EB Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789 [TBL] [Abstract][Full Text] [Related]
20. Role of the renin-angiotensin-aldosterone system in collecting duct-derived endothelin-1 regulation of blood pressure. Ge Y; Huang Y; Kohan DE Can J Physiol Pharmacol; 2008 Jun; 86(6):329-36. PubMed ID: 18516095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]